Keros Therapeutics, Inc.

$66.58 $3.43 5.4%

Price as of February 24, 2021, 9:00 p.m. EST View Interactive KROS Charts

Interactive Chart

David Haen | Apr 23, 2020

These companies just raised significant cash to advance promising drug pipelines.

Primary metrics and data points about Keros Therapeutics, Inc..

What our community thinks about Keros Therapeutics, Inc.

CAPS Rating

0 Outperform

0 Underperform

CAPS All Stars

0 Outperform

0 Underperform

The single most important factor in a company's success is the team that's leading the company

Keros Therapeutics, Inc.

Sector: Health Care
Industry: Pharmaceuticals

99 Hayden Avenue Suite 120
Lexington, MA 02421
United States
www.kerostx.com